167 related articles for article (PubMed ID: 21222340)
1. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer.
Kikuchi R; Abe Y; Iijima K; Koike T; Ara N; Uno K; Asanuma K; Asano N; Imatani A; Shimosegawa T
Tohoku J Exp Med; 2011 Jan; 223(1):35-44. PubMed ID: 21222340
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
6. Serological assessment of gastric mucosal atrophy in gastric cancer.
Bornschein J; Selgrad M; Wex T; Kuester D; Malfertheiner P
BMC Gastroenterol; 2012 Jan; 12():10. PubMed ID: 22289789
[TBL] [Abstract][Full Text] [Related]
7. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
8. Histologic and serum risk markers for noncardia early gastric cancer.
Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
[TBL] [Abstract][Full Text] [Related]
9. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
10. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
12. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
[TBL] [Abstract][Full Text] [Related]
13. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.
Rembiasz K; Konturek PC; Karcz D; Konturek SJ; Ochmanski W; Bielanski W; Budzynski A; Stachura J
Dig Dis Sci; 2005 Mar; 50(3):474-82. PubMed ID: 15810629
[TBL] [Abstract][Full Text] [Related]
15. The non-invasive diagnosis of precancerous changes of stomach mucosa.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
[TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
Wang Y; Zhu Z; Liu Z; Zhao Z; Xue X; Li X; Li P; Rong G; Ma Y
J Int Med Res; 2020 Mar; 48(3):300060520914826. PubMed ID: 32228342
[TBL] [Abstract][Full Text] [Related]
18. [Potentialities of a serological method in diagnosis of atrophic gastritis].
Pimenov SI; Makarenko EV
Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
[TBL] [Abstract][Full Text] [Related]
19. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
[TBL] [Abstract][Full Text] [Related]
20. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Mernova VP; Polyakova MB
Scand J Gastroenterol; 2005 Mar; 40(3):297-301. PubMed ID: 15932170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
